IPR In Benefit-Sharing Agreements For Genetic Resources.
✅ 1. What is Benefit-Sharing in Genetic Resources?
Benefit-sharing refers to the fair and equitable sharing of benefits arising from the use of genetic resources (plants, microbes, animals, etc.) and associated traditional knowledge.
This concept is central to the Convention on Biological Diversity (CBD) and its Nagoya Protocol.
Types of benefits:
✔ Monetary benefits
royalties
upfront payments
milestone payments
✔ Non-monetary benefits
technology transfer
capacity building
joint research
sharing of research results
training
✅ 2. Role of IPR in Benefit-Sharing Agreements
When genetic resources are used to develop commercial products (drugs, seeds, enzymes), IPR becomes crucial:
Why IPR matters:
Who owns the invention?
Who has the right to patent?
Who is entitled to benefits?
Can the traditional knowledge holder claim ownership?
What if a community’s knowledge was used without consent?
Typical IPR issues in BSAs
✔ Patents on:
gene sequences
biotechnological processes
derivatives
plant varieties
✔ Ownership disputes
Researchers vs. Indigenous communities
Companies vs. national governments
Universities vs. local farmers
✔ Terms in BSAs
Prior informed consent (PIC)
Mutually agreed terms (MAT)
Benefit-sharing clause
IP ownership clause
Publication rights
✅ 3. Key Principles in BSA-IPR Relationship
A. Prior Informed Consent (PIC)
Before accessing genetic resources, the user must obtain permission.
B. Mutually Agreed Terms (MAT)
Terms of use and benefit-sharing must be negotiated.
C. Disclosure of Origin
Some countries require patent applicants to disclose the origin of genetic resources.
✅ 4. Case Laws: Detailed Explanations (More than 5)
🔹 **Case 1: The “Turmeric Patent” Case (India vs. USA)
Case Name: The EPO and US Patent for Turmeric
Year: 1995
Facts:
A company in the USA patented the use of turmeric as a wound healing agent.
Turmeric was traditionally used in India for wound healing for centuries.
Issue:
Whether the patent should be granted despite prior traditional knowledge.
Decision:
The patent was revoked because:
The use of turmeric as wound healing was already known in India.
It was not novel or inventive.
Significance:
It shows that traditional knowledge can defeat patents.
It strengthened the argument that benefit-sharing is mandatory when traditional knowledge is involved.
🔹 **Case 2: The Neem Patent Case
Case Name: Neem Patent Case
Year: 2000
Facts:
A European company patented a process using neem extracts for pesticides.
Neem has been traditionally used in India for pest control for centuries.
Issue:
Whether the patent is valid given prior knowledge.
Decision:
The patent was revoked because:
The knowledge was already in public domain in India.
It lacked novelty and inventive step.
Significance:
This case highlighted biopiracy and the need for benefit-sharing.
It strengthened India’s Traditional Knowledge Digital Library (TKDL).
🔹 **Case 3: The Basmati Rice Case
Case Name: RiceTec Inc. vs. Indian Government
Year: 2001
Facts:
RiceTec (US) filed patents on Basmati rice varieties.
India argued it was traditional Indian rice.
Issue:
Whether the patent can be granted for Basmati rice.
Decision:
Many patents were revoked or limited.
The case highlighted the concept of “misappropriation of traditional resources.”
Significance:
It showed that traditional rice varieties cannot be patented without benefit-sharing.
🔹 **Case 4: The Rosy Periwinkle Case
Case Name: Vincristine & Vinblastine (Periwinkle plant)
Year: 1950s-1970s (ongoing debates)
Facts:
Madagascar’s periwinkle plant led to drugs used for leukemia.
The plant’s knowledge was traditionally used by indigenous people.
Issue:
Whether Madagascar and the indigenous communities should receive benefits.
Decision:
No formal benefit-sharing agreement existed.
The pharmaceutical company patented the drugs.
Significance:
A classic example of biopiracy.
Led to global discussion on equitable benefit-sharing.
🔹 **Case 5: The Hoodia Cactus Case
Case Name: San People vs. South Africa / Phytopharm
Year: 2003-2010
Facts:
Hoodia cactus was used by San people to suppress appetite.
A UK company patented Hoodia derivatives.
Issue:
Whether the San people should receive benefits.
Decision:
A benefit-sharing agreement was eventually reached.
San people received royalties.
Significance:
A successful example of BSA.
Shows how IP can be linked to benefit-sharing.
🔹 **Case 6: The Kani (Jeevani) Case
Case Name: India’s Kani Tribe & CSIR
Year: 1999
Facts:
CSIR (India) developed a drug based on the Kani tribe’s knowledge of a plant (Arogyapacha).
The Kani tribe provided traditional knowledge.
Issue:
Whether the Kani tribe should share in benefits.
Decision:
A benefit-sharing agreement was signed.
Kani tribe received royalties.
Significance:
Landmark BSA model.
Showed how IP can be shared with indigenous communities.
🔹 **Case 7: The Enola Bean Case
Case Name: Mexican Bean (Enola Bean)
Year: 1999
Facts:
A US company patented a yellow bean variety from Mexico.
Mexico argued it was traditional.
Issue:
Whether the patent was valid.
Decision:
Patent was revoked.
The court held it lacked novelty and was based on traditional knowledge.
Significance:
Reinforced prior art and traditional knowledge as defenses.
✅ 5. Legal Principles from the Cases
From the above cases, we derive the following key principles:
✔ Traditional knowledge can defeat patents
If knowledge is already known publicly, patents are invalid.
✔ Benefit-sharing is not optional
If traditional knowledge or genetic resources are used, benefits must be shared.
✔ IPR is not absolute
The public interest, biodiversity, and indigenous rights can limit IP rights.
✔ Disclosure of origin
Many courts require that origin of genetic resources be disclosed.
✅ 6. Conclusion
Benefit-sharing agreements in genetic resources are designed to:
protect indigenous rights
prevent biopiracy
ensure fair distribution of profits
encourage ethical research and innovation
IPR is central because it defines who benefits and how much.
RELATED Blog
comments